Related Experiment Video
Updated: Jul 18, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Trends and disparities in China's cardiovascular disease burden from 1990 to 2019
Jiale Zhang1, Hongxuan Tong1, Lijie Jiang1
1Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Insights
Cardiovascular disease (CVD) prevalence in China has surged by 140% since 1990, with metabolic risks like high blood pressure being major contributors. Projections indicate a stabilization and decline in CVD burden by 2030.
Area of Science:
- Epidemiology
- Public Health
- Cardiovascular Disease Research
Background:
- Cardiovascular diseases (CVD) pose a significant public health challenge, necessitating systematic assessment of risk factors for effective prevention strategies.
- Understanding long-term trends and epidemiological characteristics of CVD in China is crucial given its large and aging population.
Purpose of the Study:
- To systematically assess the burden of cardiovascular diseases (CVD) in China using the Global Burden of Disease (GBD) 2019 study.
- To analyze long-term trends, epidemiological characteristics, and attributable risk factors of CVD in the Chinese population.
Main Methods:
- Comprehensive analysis of CVD burden metrics including prevalence, incidence, mortality, YLLs, YLDs, and DALYs using GBD 2019 data.
- Application of joinpoint regression, age-period-cohort (APC) models, and Bayesian APC (BAPC) for trend analysis and mortality/morbidity prediction.
- Investigation of CVD-attributable risk factors, with a focus on metabolic risks.
Main Results:
- CVD prevalence in China reached 120 million in 2019, a 140.02% increase from 1990, with a 52.56% rise in CVD-attributed DALYs.
- While incidence showed a fluctuating downward trend, mortality significantly declined. Recent generations exhibit higher prevalence, and prevalence is increasing within age groups.
- BAPC predictions suggest CVD prevalence and mortality will stabilize and decline between 2020-2030, particularly in males. High blood pressure was identified as the primary metabolic risk factor.
Conclusions:
- The substantial and increasing burden of CVD in China, exacerbated by an aging population, represents a major public health concern.
- Urgent development and implementation of practical strategies for CVD prevention and management are essential to mitigate this growing health challenge.
Background And Aims:
In order to find the exact strategies in the prevention of cardiovascular diseases (CVD), it is necessary to assess their risk factors systematically. Here, we used the Global Burden of Disease (GBD) to review the long-term trends and epidemiological characteristics among Chinese.
Methods And Results:
We comprehensively analyzed the burden of CVD for the Chinese population using GBD 2019, including prevalence, incidence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs). Then, we analyzed trends over time, and predicted mortality and morbidity, using joinpoint regression, age-period-cohort (APC) model, and Bayesian APC approach. Finally, we analyzed the attributable burden of CVD. In 2019, the prevalence of CVD in China was 120 million, representing a 140.02% increase since 1990. The number of DALYs attributed to CVD increased by 52.56% compared to 1990. Joinpoint showed a fluctuating incidence downward, while mortality significantly declined. The APC fitting results indicated that recent generations have a higher prevalence than the past, and the prevalence has increased among individuals of the same age group. The BAPC predicted that CVD's prevalence and mortality in the Chinese would stabilize and decline between 2020 and 2030, with a significant decline among males. The main CVD-attributable burdens in 2019 were metabolic risks, especially high blood pressure.
Conclusion:
Given China's large and rapidly aging population, the burden of CVD is a major concern. Practical strategies to prevent and manage CVD are urgently needed to address this public health challenge.
More Related Videos
05:15Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Coronary Artery Disease I: Introduction
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...